ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Scope Of Panel’s Inquiry Outlined In Letter To Members

July 22, 1994

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

Greenberg: More Work Needs to be Done

November 7, 2014

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

June 26, 1992

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979